查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945362

2026年全球體外癌症診斷市場報告

In Vitro Cancer Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外癌症診斷市場發展迅猛，預計將從2025年的114.9億美元成長到2026年的123.6億美元，複合年成長率達7.6%。過去幾年的成長可歸因於癌症發病率上升、分子診斷方法的廣泛應用、免疫檢測試劑盒的開發、診斷檢查室的擴張以及試劑技術的進步等因素。

預計未來幾年體外癌症診斷市場將維持強勁成長，2030年市場規模將達到167.8億美元，複合年成長率（CAGR）為7.9%。預測期內的成長要素包括基於人工智慧的預測分析、個人化癌症治療的擴展、高通量定序平台的開發、照護現場診斷的成長以及雲端診斷軟體的普及。預測期內的關鍵趨勢包括基於生物標記的檢測、基因譜分析工具、多重檢測方法的開發、與實驗室資訊管理系統（LIMS）的整合以及快速診斷試劑盒。

預計未來幾年，液態生物檢體技術的日益普及將推動體外癌症診斷市場的成長。液態生物檢體技術是一種微創診斷方法，它能夠檢測和分析存在於血液、尿液和唾液等體液中的生物標記物，例如循環腫瘤DNA、循環性腫瘤細胞和外泌體，從而監測癌症的存在、進展和治療反應，尤其適用於癌症的診斷。從血液和其他體液中分離和分析循環腫瘤DNA和循環性腫瘤細胞技術的進步，促成了液態生物檢體技術的廣泛應用。液態生物檢體技術的快速普及，推動了對體外癌症診斷解決方案的需求，而這種需求的驅動力在於非侵入性、即時分子分析工具在癌症檢測和治療指導方面的應用。例如，據英國國家醫療服務體系（NHS England）稱，到2025年5月，英國新推出的液態生物檢體血液檢測預計每年將使多達15,000名疑似肺癌患者和5,000名進行性乳癌女性患者受益。預計檢測對象數量將從2025年初推出時的約2,200人增加到2028年的每年約20,000人。因此，液態生物檢體技術的日益普及正在推動體外癌症診斷市場的成長。

體外癌症診斷市場的主要企業正致力於開發人工智慧驅動的癌症診斷技術，旨在改善患者預後並促進個人化醫療。人工智慧驅動的癌症診斷利用人工智慧分析從患者檢體、影像和基因檢測中獲得的醫學和分子數據，從而實現高度精準的癌症檢測、診斷和預測。例如，總部位於瑞士的製藥公司羅氏於2024年9月推出了數位病理開放環境（Digital Pathology Open Environment），這是一個協作平台，可安全地整合羅氏和多家第三方開發人員的先進人工智慧影像分析工具。該平台使病理學家能夠存取羅氏Navifify數位病理企業軟體中的創新演算法，從而提高診斷準確性和工作流程效率。透過促進協作和數據共用，該平台加速了癌症診斷和監測領域的創新，支持精準醫療，實現了更有效的標靶治療，並擴大了全球先進數位病理解決方案的獲取途徑。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外癌症診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 身臨其境型技術（AR/VR/XR）與數位體驗
  • 主要趨勢
    • 基於生物標記的檢測
    • 基因譜分析工具
    • 多重檢測方法的開發
    • 與實驗室資訊管理系統（LIMS）整合
    • 快速診斷試劑盒

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 研究所
  • 居家醫療環境
  • 腫瘤中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外癌症診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球體外癌症診斷市場規模、比較及成長率分析
  • 全球體外癌症診斷市場表現：規模與成長，2020-2025年
  • 全球體外癌症診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品類型
  • 試劑盒、儀器、試劑、軟體及耗材
  • 透過技術
  • 聚合酵素鏈鎖反應（PCR）、次世代定序（NGS）、螢光原位雜合反應（FISH）、免疫組織化學及其他技術
  • 透過使用
  • 乳癌、肺癌、結腸癌、攝護腺癌及其他應用領域
  • 最終用戶
  • 醫院、診斷檢查室、研究實驗室和其他最終用戶
  • 按類型細分：套裝
  • 免疫檢測盒、聚合酵素鏈鎖反應（PCR）試劑盒、酵素免疫分析法（ELISA）試劑盒、流式細胞技術盒
  • 按類型細分：設備
  • 聚合酵素鏈鎖反應（PCR）儀、定序儀、流式細胞儀、影像系統
  • 按類型細分：試劑
  • 酵素、緩衝液、探針和染色劑
  • 按類型細分：軟體
  • 數據分析軟體、影像處理軟體、實驗室資訊管理系統（LIMS）軟體、診斷報告軟體
  • 按類型細分：消耗品
  • 微孔盤、微量吸管尖、試管、玻片

第10章 區域與國家分析

  • 全球體外癌症診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球體外癌症診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體外癌症診斷市場：競爭格局與市場佔有率，2024 年
  • 體外癌症診斷市場：公司估值矩陣
  • 體外癌症診斷市場：公司概況
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Siemens Healthineers AG

第37章：其他領先和創新企業

  • Illumina Inc, Hologic Inc, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company（BD）, Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年體外癌症診斷市場：提供新機會的國家
  • 2030年體外癌症診斷市場：新興細分市場機會
  • 2030年體外癌症診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MIVCD01_G26Q1

In vitro cancer diagnostics refers to laboratory-based tests conducted on samples such as blood, tissue, or other body fluids to detect, monitor, or evaluate cancer outside the human body. These diagnostics employ techniques like molecular assays, biomarker analysis, and genetic profiling to identify the presence or progression of cancer. They support early detection, accurate diagnosis, and informed treatment planning for patients.

The key product types in in vitro cancer diagnostics include kits, instruments, reagents, software, and consumables. Kits are ready-to-use sets of reagents and materials designed for diagnostic testing, enabling biomarker detection, supporting disease monitoring, and assisting in treatment evaluation. Technologies used include polymerase chain reaction (PCR), next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), immunohistochemistry, and others. These diagnostics are applied across multiple cancer types, including breast cancer, lung cancer, colorectal cancer, and prostate cancer, and serve end users such as hospitals, diagnostic laboratories, research institutes, home care settings, and others.

Tariffs are impacting the in vitro cancer diagnostics market by increasing costs of instruments, kits, reagents, and software components. Kits and instruments are most affected, particularly in North America and Europe due to import dependence. Positive effects include stimulation of local manufacturing, innovation in cost-efficient diagnostic kits, and improved domestic production capabilities.

The in vitro cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides in vitro cancer diagnostics market statistics, including in vitro cancer diagnostics industry global market size, regional shares, competitors with a in vitro cancer diagnostics market share, detailed in vitro cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro cancer diagnostics industry. This in vitro cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro cancer diagnostics market size has grown strongly in recent years. It will grow from $11.49 billion in 2025 to $12.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising cancer prevalence, adoption of molecular diagnostics, development of immunoassay kits, expansion of diagnostic laboratories, advancements in reagent technologies.

The in vitro cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to AI-enabled predictive analytics, expansion in personalized oncology, development of high-throughput sequencing platforms, growth in point-of-care diagnostics, adoption of cloud-based diagnostic software. Major trends in the forecast period include biomarker-based detection, genetic profiling tools, multiplex assay development, integration with laboratory information systems (lims), rapid diagnostic kits.

The rising adoption of liquid biopsy technologies is expected to enhance the growth of the in vitro cancer diagnostics market in the coming years. Liquid biopsy technologies refer to minimally invasive diagnostic methods that detect and analyze biomarkers such as circulating tumor DNA, circulating tumor cells, or exosomes present in body fluids like blood, urine, or saliva to monitor disease presence, progression, or response to treatment, particularly in cancer. The use of liquid biopsy technologies is increasing due to advancements in isolating and analyzing circulating tumor DNA and circulating tumor cells from blood and other body fluids. In vitro cancer diagnostic solutions are experiencing higher demand as the rapid adoption of liquid biopsy technologies encourages companies to implement non invasive and real time molecular profiling tools for cancer detection and treatment guidance. For example, in May 2025, according to NHS England, a UK based public healthcare system, the new liquid biopsy blood test rollout in the UK is expected to benefit up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer annually, expanding from about 2,200 patients tested during the early 2025 rollout to an estimated 20,000 patients per year by 2028. Therefore, the rising adoption of liquid biopsy technologies is enhancing the growth of the in vitro cancer diagnostics market.

Leading companies operating in the in vitro cancer diagnostics market are emphasizing the development of AI-driven cancer diagnostics to improve patient outcomes and advance personalized healthcare. AI-driven cancer diagnostics involve the use of artificial intelligence to analyze medical and molecular data from patient samples, imaging, or genetic tests, enabling highly accurate detection, diagnosis, and prediction of cancer. For instance, in September 2024, Roche, a Switzerland-based pharmaceutical company, introduced the Digital Pathology Open Environment, a collaborative platform that securely integrates advanced AI-based image analysis tools from Roche and multiple third-party developers. The platform allows pathologists to access innovative algorithms within Roche's Navify Digital Pathology enterprise software, enhancing diagnostic precision and workflow efficiency. By fostering collaboration and data sharing, the platform accelerates innovation in cancer diagnostics and research, supports precision medicine, and enables more effective targeted treatments, expanding global access to advanced digital pathology solutions.

In February 2024, Veracyte Inc., a US-based molecular diagnostics company, acquired C2i Genomics, Inc. for an undisclosed amount. Through this acquisition, Veracyte aims to expand its presence across the cancer care continuum by incorporating AI-driven whole-genome minimal residual disease testing to enhance treatment monitoring and detect disease recurrence. C2i Genomics Inc. is a US-based biotechnology company that provides in vitro cancer diagnostics.

Major companies operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics

North America was the largest region in the in vitro cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in vitro cancer diagnostics market consists of revenues earned by entities by providing services such as molecular diagnostic testing, biopsy and cytology analysis, companion diagnostic services, and next-generation sequencing (NGS) services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro cancer diagnostics market also includes sales of cancer biomarker kits, molecular diagnostic assays, flow cytometry kits, tissue-based diagnostic kits, and genomic testing panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Cancer Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Kits; Instruments; Reagents; Software; Consumables
  • 2) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Fluorescence In Situ Hybridization (FISH); Immunohistochemistry; Other Technologies
  • 3) By Application: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Kits: Immunoassay Kits; Polymerase Chain Reaction (PCR) Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Flow Cytometry Kits
  • 2) By Instruments: Polymerase Chain Reaction (PCR) Instruments; Sequencers; Flow Cytometers; Imaging Systems
  • 3) By Reagents: Enzymes; Buffers; Probes; Stains
  • 4) By Software: Data Analysis Software; Imaging Software; Laboratory Information Management System (LIMS) Software; Diagnostic Reporting Software
  • 5) By Consumables: Microplates; Pipette Tips; Tubes; Slides
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Danaher Corporation; Abbott Laboratories; Thermo Fisher Scientific; Siemens Healthineers AG; Illumina Inc; Hologic Inc; Qiagen N.V; Bio-Rad Laboratories Inc; Agilent Technologies; Becton; Dickinson and Company (BD); Sysmex Corporation; LabCorp Holding Corp.; Guardant Health; Quest Diagnostics; Exact Sciences; Myriad Genetics Inc; Natera Inc.; NeoGenomics Laboratories; NanoString Technologies Inc; Caris Life Sciences; Transasia Bio-Medicals Ltd; Autobio Diagnostics Co Ltd; QuidelOrtho Corporation; Cancer Diagnostics Inc; Predicine Inc; Strata Oncology; Biocept Inc; Lucence Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In Vitro Cancer Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In Vitro Cancer Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In Vitro Cancer Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In Vitro Cancer Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Biomarker-Based Detection
    • 4.2.2 Genetic Profiling Tools
    • 4.2.3 Multiplex Assay Development
    • 4.2.4 Integration With Laboratory Information Systems (Lims)
    • 4.2.5 Rapid Diagnostic Kits

5. In Vitro Cancer Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Home Care Settings
  • 5.5 Oncology Centers

6. In Vitro Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In Vitro Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In Vitro Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In Vitro Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In Vitro Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Cancer Diagnostics Market Segmentation

  • 9.1. Global In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits, Instruments, Reagents, Software, Consumables
  • 9.2. Global In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Other Technologies
  • 9.3. Global In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Applications
  • 9.4. Global In Vitro Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
  • 9.5. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassay Kits, Polymerase Chain Reaction (PCR) Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Flow Cytometry Kits
  • 9.6. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Instruments, Sequencers, Flow Cytometers, Imaging Systems
  • 9.7. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzymes, Buffers, Probes, Stains
  • 9.8. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Imaging Software, Laboratory Information Management System (LIMS) Software, Diagnostic Reporting Software
  • 9.9. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microplates, Pipette Tips, Tubes, Slides

10. In Vitro Cancer Diagnostics Market Regional And Country Analysis

  • 10.1. Global In Vitro Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In Vitro Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Cancer Diagnostics Market

  • 11.1. Asia-Pacific In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Cancer Diagnostics Market

  • 12.1. China In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Cancer Diagnostics Market

  • 13.1. India In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Cancer Diagnostics Market

  • 14.1. Japan In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Cancer Diagnostics Market

  • 15.1. Australia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Cancer Diagnostics Market

  • 16.1. Indonesia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Cancer Diagnostics Market

  • 17.1. South Korea In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In Vitro Cancer Diagnostics Market

  • 18.1. Taiwan In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In Vitro Cancer Diagnostics Market

  • 19.1. South East Asia In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In Vitro Cancer Diagnostics Market

  • 20.1. Western Europe In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In Vitro Cancer Diagnostics Market

  • 21.1. UK In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In Vitro Cancer Diagnostics Market

  • 22.1. Germany In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In Vitro Cancer Diagnostics Market

  • 23.1. France In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In Vitro Cancer Diagnostics Market

  • 24.1. Italy In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In Vitro Cancer Diagnostics Market

  • 25.1. Spain In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In Vitro Cancer Diagnostics Market

  • 26.1. Eastern Europe In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In Vitro Cancer Diagnostics Market

  • 27.1. Russia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In Vitro Cancer Diagnostics Market

  • 28.1. North America In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In Vitro Cancer Diagnostics Market

  • 29.1. USA In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In Vitro Cancer Diagnostics Market

  • 30.1. Canada In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In Vitro Cancer Diagnostics Market

  • 31.1. South America In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In Vitro Cancer Diagnostics Market

  • 32.1. Brazil In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In Vitro Cancer Diagnostics Market

  • 33.1. Middle East In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In Vitro Cancer Diagnostics Market

  • 34.1. Africa In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In Vitro Cancer Diagnostics Market Regulatory and Investment Landscape

36. In Vitro Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. In Vitro Cancer Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In Vitro Cancer Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In Vitro Cancer Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. In Vitro Cancer Diagnostics Market Other Major And Innovative Companies

  • Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc

38. Global In Vitro Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In Vitro Cancer Diagnostics Market

40. In Vitro Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 In Vitro Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In Vitro Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In Vitro Cancer Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer